User profiles for Markella Zannikou
Markella ZannikouResearch Assistant Professor, Northwestern University Verified email at northwestern.edu Cited by 677 |
[HTML][HTML] STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
…, Y Han, A Lopez-Rosas, M Zannikou… - Nature …, 2023 - nature.com
As a key component of the standard of care for glioblastoma, radiotherapy induces several
immune resistance mechanisms, such as upregulation of CD47 and PD-L1. Here, leveraging …
immune resistance mechanisms, such as upregulation of CD47 and PD-L1. Here, leveraging …
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial
Background Malignant glioma is the most common and lethal primary brain tumour, with
dismal survival rates and no effective treatment. We examined the safety and activity of NSC-…
dismal survival rates and no effective treatment. We examined the safety and activity of NSC-…
[PDF][PDF] Hepatocyte autotaxin expression promotes liver fibrosis and cancer
…, A Katsifa, N Xylourgidis, I Ninou, M Zannikou… - …, 2017 - Wiley Online Library
Autotaxin (ATX) is a secreted lysophospholipase D that catalyzes the production of
lysophosphatidic acid (LPA), a pleiotropic growth‐factor–like lysophospholipid. Increased ATX …
lysophosphatidic acid (LPA), a pleiotropic growth‐factor–like lysophospholipid. Increased ATX …
Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma
Tumor-associated myeloid cells (TAMCs) are key drivers of immunosuppression in the
tumor microenvironment, which profoundly impedes the clinical response to immune-dependent …
tumor microenvironment, which profoundly impedes the clinical response to immune-dependent …
Interfering with Metabolic Profile of Triple‐Negative Breast Cancers Using Rationally Designed Metformin Prodrugs
…, KR Chong, P Rapta, M Zannikou… - Angewandte Chemie …, 2021 - Wiley Online Library
Triple‐negative breast cancer (TNBC) is the most aggressive subtype of breast cancer,
characterized by an aberrant metabolic phenotype with high metastatic capacity, resulting in poor …
characterized by an aberrant metabolic phenotype with high metastatic capacity, resulting in poor …
Mesenchymal stem cells successfully deliver oncolytic virotherapy to diffuse intrinsic pontine glioma
MI Chastkofsky, KC Pituch, H Katagi, M Zannikou… - Clinical Cancer …, 2021 - AACR
Purpose: Diffuse intrinsic pontine glioma (DIPG) is among the deadliest of pediatric brain
tumors. Radiotherapy is the standard-of-care treatment for DIPG, but offers only transient relief …
tumors. Radiotherapy is the standard-of-care treatment for DIPG, but offers only transient relief …
[HTML][HTML] IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM
M Zannikou, JT Duffy, RN Levine… - … for immunotherapy of …, 2023 - ncbi.nlm.nih.gov
Methods RNA-seq, RT-qPCR, and flow cytometry were used to determine IL15Rα expression
in paired peripheral and tumor-infiltrating immune cells of GBM patients and two syngeneic …
in paired peripheral and tumor-infiltrating immune cells of GBM patients and two syngeneic …
[HTML][HTML] Protein tyrosine phosphatase-1B inhibition disrupts IL13Rα2-promoted invasion and metastasis in cancer cells
Background: Interleukin 13 receptor alpha 2 subunit (IL13Rα2) is overexpressed in
glioblastoma (GBM), metastatic colorectal cancer (CRC) and ovarian cancer (OC). Here, we …
glioblastoma (GBM), metastatic colorectal cancer (CRC) and ovarian cancer (OC). Here, we …
Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint Inhibitors
SE Fenton, M Zannikou, L Ilut, M Fischietti, C Ji… - Molecular Cancer …, 2023 - AACR
… Markella Zannikou … Markella Zannikou … Fenton, Markella Zannikou, Liliana Ilut,
Mariafausta Fischietti, Chunni Ji, Chidera V. Oku, Curt M. Horvath, I. …
Mariafausta Fischietti, Chunni Ji, Chidera V. Oku, Curt M. Horvath, I. …
MAP3K8 Regulates Cox-2–Mediated Prostaglandin E2 Production in the Lung and Suppresses Pulmonary Inflammation and Fibrosis
M Zannikou, I Barbayianni, D Fanidis… - The Journal of …, 2021 - journals.aai.org
Idiopathic pulmonary fibrosis (IPF) is characterized by exuberant deposition of extracellular
matrix components, leading to the deterioration of lung architecture and respiratory functions. …
matrix components, leading to the deterioration of lung architecture and respiratory functions. …